Although these studies indicate that both pathways are interconnected, there is a need to explore more precisely whether this is occurring, opening the possibility of developing anti-tumor therapies that target both the SAC and the repair mechanisms in defective ATM/ATR cells so that the cells are selectively destroyed. The gene discussed is ADCY10; the disease is neoplasm.